In the news

Dr. Ken Stein, SVP and chief global medical officer, discusses the tremendous opportunities to use digital capabilities in medtech.

Dr. Janar Sathananthan, chief medical officer, Interventional Cardiology Therapies, discusses a new treatment option in the U.S. for patients with coronary artery disease who experience in-stent restenosis.

Wendy Carruthers, executive vice president of human resources, describes hybrid work as the best of both worlds with benefits for employees and employers alike.

Boston Scientific announced that it has entered into a definitive agreement to acquire Silk Road Medical, Inc., a medical device company that has developed an innovative platform of products to prevent stroke in patients with carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization (TCAR).

Boston Scientific announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRM™ System, the first modular cardiac rhythm management (CRM) system that consists of the EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) System and the EMPOWER™ Leadless Pacemaker (LP).